New HPV vaccine batch trial aims to ensure reliable protection
NCT ID NCT07668271
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial is testing whether three different batches of a 9-valent HPV vaccine produce similar immune responses in 720 women aged 18-30 in China. Participants will receive three doses over six months, and researchers will measure antibody levels one month after the final dose. The goal is to ensure consistent quality for international approval.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
9-valent HPV vaccine (Cecolin 9)
What this could lead to
If successful, this could confirm that the vaccine works consistently across batches, supporting its use in preventing HPV infections and related cancers.
What could go wrong
This is a late-stage consistency trial, not a test of effectiveness. It may not show how well the vaccine prevents disease in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTION BY HUMAN PAPILLOMA VIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhangping Center for Disease Control and Prevention
RECRUITINGZhangping, Fujian, 364400, China